4 days Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready To Meet Demand?The Wall Street Journal

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ramp up production enough.

Eli Lilly (LLY)

6 hours Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired DropYahoo Finance X

14 hours Jim Cramer on Eli Lilly and Company (LLY): ‘I’m Kind Of Blown Away’Insider Monkey X

18 hours UnitedHealth, Eli Lilly Lead Market Cap Stock Movers on WednesdayInvesting.com X

1 day Is It Time to Sell Eli Lilly and Pfizer Stocks?Yahoo Finance X

1 day Is It Time to Sell Eli Lilly and Pfizer Stocks?The Motley Fool X

1 day The Zacks Analyst Blog Highlights Eli Lilly, PepsiCo and Morgan StanleyZacks X

2 days Top Research Reports for Eli Lilly, PepsiCo & Morgan StanleyZacks X

2 days LLY Oral Cholesterol Drug Lowers Lipoprotein Levels in Phase II StudyZacks X

2 days Here’s Why Eli Lilly and Company (LLY) is on Detractors’ List of Madison Sustainable Equity FundInsider Monkey X

2 days Makers of Weight-Loss Drugs Want Your Employer to Pay for ThemThe Wall Street Journal X

3 days Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should KnowZacks X

3 days Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-203024/7 Wall St. X

3 days 3 Growth Stocks You Can Buy Right Now Without Any HesitationThe Motley Fool X

6 days Three-Stock Lunch: Eli Lilly, Transdigm, & NvidiaYouTube X

6 days Eli Lilly, J&J Sue US Over Rejected Changes To Drug Discounting ProgramYahoo Finance X

6 days Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?The Motley Fool X

7 days Is Eli Lilly Stock A Sell After Its Disastrous Third-Quarter Report?Investor's Business Daily X

1 week Is AstraZeneca a Buy as It Eyes the Weight Loss Market?The Motley Fool X

1 week 2 Top Growth Stocks to Buy on the DipThe Motley Fool X

1 week Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?Investor's Business Daily X

1 week Did Viking Therapeutics Just Say “Checkmate” To Eli Lilly?The Motley Fool X

1 week Eli Lilly Falls More Than 10% in a Month: Buy, Sell or Hold the Stock?Zacks X

2 weeks Eli Lilly and Company (LLY): Ken Fisher’s Bet on a Pharma Giant’s Growth PotentialInsider Monkey X

2 weeks 1 Stubborn Cloud and 2 Silver Linings for Eli Lilly StockThe Motley Fool X

2 weeks Eli Lilly and Company (LLY): Among the Best Low Volatility Stocks to Invest In NowInsider Monkey X

2 weeks Micron tops list of 20 biggest winners in the S&P 500 this earnings seasonMarketWatch X

2 weeks Eli Lilly Just Hit a Milestone That Disappointed. Here’s Why You Should Still Buy the Stock.The Motley Fool X

2 weeks What Makes Eli Lilly & Co (LLY) a Prospective Investment?Insider Monkey X

2 weeks Eli Lilly Posts a Huge Earnings Miss. Should Investors Be Worried?The Motley Fool X

2 weeks Missed Out on Eli Lilly? Buy This Amazing Growth Stock InsteadThe Motley Fool X

2 weeks Should Investors Buy Weakness in These High-Growth Stocks?Zacks X

2 weeks Is Eli Lilly and Company (LLY) the Best Pharma Stock to Buy Right Now?Insider Monkey X

2 weeks Americans seeking Eli Lilly and Novo Nordisk’s weight-loss drugs turn to compounded marketFast Company X

2 weeks Big Pharma’s Obesity Bonanza Faces New TestsThe Wall Street Journal X

3 weeks Could This Near Trillion-Dollar Stock Be a Millionaire Maker?The Motley Fool X

3 weeks Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY’s Q3 Earnings in FocusZacks X

3 weeks Three Buys and a Bail: Microsoft, Eli Lilly, Peloton, and SnapYouTube X

3 weeks Leerink Partnrs Issues Pessimistic Forecast for LLY EarningsMarketBeat X

3 weeks Why Eli Lilly Is a No-Brainer Stock to Buy on the DipThe Motley Fool X

3 weeks Eli Lilly Earnings Have Wall Street Asking New Questions About GLP-1 Drugs. Is Something Going Wrong?Yahoo Finance X

3 weeks Eli Lilly and Company (NYSE:LLY): Among The 10 Best S&P 500 Stocks to Buy According to Hedge FundsInsider Monkey X

3 weeks Are Eli Lilly’s Lowered Expectations a Reason to Sell?The Motley Fool X

3 weeks Eli Lilly’s miss explanation is ‘totally opaque’, says Jim CramerYouTube X

3 weeks Eli Lilly’s drop after earnings is a buying opportunity, says Mizuho’s Jared HolzYouTube X

3 weeks How major US stock indexes fared Wednesday, 10/30/2024MarketBeat X

3 weeks AMD, Eli Lilly slide; Google, Visa rise among Wednesday’s afternoon market cap stock moversInvesting.com X

3 weeks Eli Lilly (LLY) Q3 2024 Earnings Call TranscriptThe Motley Fool X

3 weeks Eli Lilly stock tumbles on Q3 miss, Zepbound sales fall shortYouTube X

3 weeks Lilly’s Q3 Earnings Miss, Mounjaro, Zepbound Disappoint, Stock TanksZacks X

3 weeks Why Eli Lilly Stock Is Sinking TodayThe Motley Fool X